TSE:MFC

Manulife Financial (MFC.TO)

61.42
+1.50 (2.50%)
as of Sep 3, 2026, 8:00:00 pm Market Open.
1632 watching
0
Investor Insights
star iconSep 3, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered a mixture of opinions from analysts following its recent quarterly report, which showcased positive developments despite facing challenges such as a new tax on its products for mainland Chinese residents. The company is noted for its strong presence in Asia and steady growth in its wealth management segment, which remains a highlight in its long-term strategy. However, some experts express caution, labeling MFC as a bit overvalued relative to its earnings growth potential, currently trading over 2x book value. The financial landscape for insurers in Canada appears competitive, with both MFC and its peers like TD exhibiting relatively robust performance, yet the consensus leans toward a cautious approach due to market conditions. Overall, while MFC benefits from high dividends and solid asset management, uncertainties related to its exposure to market fluctuations warrant careful monitoring for potential entry points.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
TOP PICK
Has flat lined in this bear market which historically means coming out of the bear market it will perform very well. A world leader with great growth potential. Wait for the market to settle down before buying.
HOLD
Has held up very well. If you are a trader, you may want to sell and switch into one of the banks, but if you are a long-term player, it is still a good hold.
BUY
The Canadian operations are really driving the company. Likes this company.
HOLD
Has executed flawlessly. A long-term core holding. At 14 X earnings, it's higher than banks which are normally 12 X’s. Wouldn't buy at this time.
DON'T BUY
Has done so well, he has reduced his holdings significantly. At 18 X trailing earnings it was becoming fully valued.
BUY
A good company to get global exposure. Should have one insurance company as a core holding. Just put it away and forget it.
BUY
Good growth. ROE is improving. International growth. A good long-term holding.
WAIT
Would be interested in this in the mid-$60’s. Has done a good job with its John Hancock acquisition. You get good US diversification.
BUY
Best life insurance company in North America. Likes their far east holdings. Have announced a stock split.
WATCH
There is still a long-term uptrend in place. You have to watch the long bonds in the US. If they go through 5.5%, financials are going to be hurt.
BUY
Looks like the end of US interest rate rises on the short end of the curve and long-term rates could move higher. This is a pretty good environment for them.
BUY ON WEAKNESS
The chart is starting to look a little bit tired and the wonders if there won't be a bit of a pullback. If it fell back below $70, he would be in with both feet.
BUY
The best managed with the best growth prospects. Will probably be making another acquisition in the next year or so in the US insurance market. They are also major players in the far east.
BUY ON WEAKNESS
It is a terrific stock. A great Canadian success story. She does not own but is waiting for a pull back to buy. No reason to sell, unless your portfolio is too saturated.
BUY
He likes Manulife. It is well diversified company globally. Possibly, could put 5-10% of your holdings into this stock. Recommends having at least 10 different stocks to diversify your holdings.
Showing 1,891 to 1,905 of 2,284 entries